A dynamic study of hepatobiliary system with131I-BSP in various liver diseases

1971 ◽  
Vol 6 (1) ◽  
pp. 18-18
Author(s):  
Y. Yumoto ◽  
T. Nanba

2021 ◽  
pp. 7-11
Author(s):  
M. A. Koroleva

Тhe well-known manifestations in psoriasis include psoriatic arthritis and psoriasis of the nails, however, at present, other conditions comorbid to psoriasis have begun to be actively studied: such as liver diseases, diabetes mellitus, diseases of the cardiovascular system, obesity, mental disorders, inflmmatory bowel diseases. and joints. In addition to similar immunological mechanisms, genes have been found that are common to psoriasis and the comorbid diseases associated with it. The article provides data on dysfunctions of the hepatobiliary system in patients with psoriasis. The article reveals the results of studies conducted by foreign and domestic authors, which have shown signifiant relationships in the severity of liver damage in psoriasis.



2020 ◽  
pp. 170-175
Author(s):  
Emilia Mikhailova ◽  
Denis Lokoshko ◽  
Elizaveta Bolshakova

The article presents the basic information about polyprenols of plant origin, as well as summarizes the scientific experience accumulated to date of their use as hepatoprotectors and means of preventing liver diseases. The conclusion is made about the relevance of their use in everyday medical practice.



2020 ◽  
Vol 48 (5) ◽  
pp. 2295-2305
Author(s):  
Jiawei Zhang ◽  
Dandan Li ◽  
Rui Zhang ◽  
Peng Gao ◽  
Rongxue Peng ◽  
...  

The role of miR-21 in the pathogenesis of various liver diseases, together with the possibility of detecting microRNA in the circulation, makes miR-21 a potential biomarker for noninvasive detection. In this review, we summarize the potential utility of extracellular miR-21 in the clinical management of hepatic disease patients and compared it with the current clinical practice. MiR-21 shows screening and prognostic value for liver cancer. In liver cirrhosis, miR-21 may serve as a biomarker for the differentiating diagnosis and prognosis. MiR-21 is also a potential biomarker for the severity of hepatitis. We elucidate the disease condition under which miR-21 testing can reach the expected performance. Though miR-21 is a key regulator of liver diseases, microRNAs coordinate with each other in the complex regulatory network. As a result, the performance of miR-21 is better when combined with other microRNAs or classical biomarkers under certain clinical circumstances.



2001 ◽  
Vol 120 (5) ◽  
pp. A725-A725
Author(s):  
M DORE ◽  
G REALDI ◽  
D MURA ◽  
D GRAHAM ◽  
A SEPULVEDA








2010 ◽  
Author(s):  
Joseph P. Barsuglia ◽  
Dahyun Yi ◽  
Alessa M. Barsuglia ◽  
Brian Jose Becker
Keyword(s):  


Sign in / Sign up

Export Citation Format

Share Document